XML 37 R27.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Share-Based Compensation (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract] |
Summary of Activity Under Share-Based Compensation Plans | The following table summarizes the activity for all stock appreciation rights, or SARs, under the Company’s share-based compensation plans for the nine months ended September 30, 2022:
|  | Number of Awards |  |  | Weighted-Average Exercise Price Per Award |  |  | Weighted-Average Remaining Contractual Term |  | Aggregate Intrinsic Value(1) |
|  | (in thousands) |  |  |  |  |  |  |  | (in millions) |
Outstanding as of December 31, 2021(2) |  |  | 2,622 |  |  | $ | 27.10 |  |  | 3.8 years |  | $ | 36.3 |
Granted |  |  | — |  |  | $ | — |  |  |  |  |  |
Exercised |  |  | (55 | ) |  | $ | 23.18 |  |  |  |  |  |
Forfeited |  |  | (226 | ) |  | $ | 24.70 |  |  |  |  |  |
Outstanding as of September 30, 2022(2) |  |  | 2,341 |  |  | $ | 27.42 |  |  | 3.2 years |  | $ | 2.2 |
Exercisable as of September 30, 2022(2) |  |  | 2,341 |  |  | $ | 27.42 |  |  | 3.2 years |  | $ | 2.2 |
Vested and expected to vest as of September 30, 2022 |  |  | 2,341 |  |  | $ | 27.42 |  |  | 3.2 years |  | $ | 2.2 |
(1) The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the SARs. (2) Includes 0.8 million performance condition SARs. The following table summarizes the activities for all restricted stock units under the Company’s share-based compensation plans for the nine months ended September 30, 2022:
|  | Number of Shares |  |  | Weighted-Average Grant Date Fair Value Per Share |
|  | (in thousands) |  |  |  |
Outstanding and nonvested as of December 31, 2021(1) |  |  | 3,400 |  |  | $ | 45.26 |
Granted(2) |  |  | 2,075 |  |  | $ | 36.06 |
Vested |  |  | (800 | ) |  | $ | 48.69 |
Forfeited(3) |  |  | (318 | ) |  | $ | 42.82 |
Outstanding and nonvested as of September 30, 2022(1) |  |  | 4,357 |  |  | $ | 40.43 |
Expected to vest as of September 30, 2022(4) |  |  | 3,463 |  |  | $ | 40.15 |
(1) Includes 1,387,708 and 913,388 performance-based restricted stock units as of September 30, 2022 and December 31, 2021, respectively, which represents the maximum amount that can vest. (2) Includes 559,430 performance-based restricted stock units. (3) Includes 94,110 performance-based restricted stock units (4) Includes 564,871 performance-based restricted stock units.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration